To ascertain the functional importance of CD44 in the context of estrogen receptor negative breast cancers, we used the CD44-expressing MDA-MB-231 cell line, which retains the CD44+/CD24−/low phenotype characteristic of tumor-initiating breast cancer cells. Here, CD44 is linked to neoplasm.